相关实验视频
Updated: Jun 10, 2025

Skeletal Muscle Gender Dimorphism from Proteomics
Published on: December 14, 2011
血蛋白质组和发生的心肌梗塞:性别特异性差异
Olga E Titova1, Shuai Yuan2, Liisa Byberg1
1Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Dag Hammarskjölds väg 14 B, 75185, Uppsala, Sweden.
这项研究确定了45种与心肌梗塞 (MI) 风险相关的循环蛋白质,揭示了新的性别特异性模式,特别是在女性中,并通过队列和遗传分析证实了这些联系.
科学领域:
- 心血管疾病研究研究
- 蛋白质组学是指蛋白质组学.
- 遗传学 是一个遗传学.
背景情况:
- 有限的基于人群的研究存在于循环蛋白和心肌梗塞 (MI) 风险在两性.
- 了解MI的蛋白质生物标志物对于风险预测和预防至关重要.
研究的目的:
- 调查循环心脏代谢蛋白与发生心脏病发作风险之间的关联.
- 探索这些蛋白质-MI关系中的潜在的性别特异性差异.
- 用队列和门德尔随机化 (MR) 分析来验证发现.
主要方法:
- 利用发现队列 (n=11,751) 进行259次蛋白质测量,并对发生的MI进行跟踪.
- 在英国生物库 (n=51,613) 进行复制分析.
- 采用MR分析,使用遗传变异作为蛋白质和MI遗传关联数据的仪器变量.
主要成果:
- 在发现和复制队列中确定了45种与事件MI相关的蛋白质.
- 观察到13个性别特定的关联,主要在女性中.
- 核磁共振分析将较高的氨酸,氨酸和RARRES2与心脏病风险的增加联系起来;TFPI,TNFRSF1A,TNFRSF1B和PGF显示了相反的关联.
结论:
- 确立了新的和证实了现有的循环蛋白与事件MI的相关性.
- 提供了多个蛋白质-MI关联中性别特异性模式的第一个证据.
- 突出显示特定蛋白质 (renin,follistatin,RARRES2) 作为潜在的心脏病发作风险因素.
更多相关视频
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
05:30Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction
Myocarditis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations
Acute Coronary Syndrome III: Diagnostic studies